← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #294 OF 1,000 MOST-CITED

Written procedures - product complaint; review, investigate

FDA cited this observation 73 times across 68 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods73
BY FISCAL YEAR
FY20247
FY20238
FY202210
FY20212
FY20205
FY20197
FY201819
FY201715

How FDA worded it — real examples

You did not make and keep written procedures to fulfill the requirements that apply to the review and investigation of a product complaint.

Wholly Liquid Nutritional Supplements LLC · Hampton, New Hampshire · Foods · 2024-06-27

You did not make and keep written procedures to fulfill the requirements that apply to the review and investigation of a product complaint.

Inca Living Corp · Boca Raton, Florida · Foods · 2024-06-24

You did not make and keep written procedures to fulfill the requirements that apply to the review and investigation of a product complaint.

Nutra Group LLC · Lake Ronkonkoma, New York · Foods · 2024-06-10

You did not make and keep written procedures to fulfill the requirements that apply to the review and investigation of a product complaint.

Source-Omega LLC · South Lebanon, Ohio · Foods · 2024-02-28

You did not make and keep written procedures to fulfill the requirements that apply to the review and investigation of a product complaint.

Talisman LLC dba American Metabolix · Richardson, Texas · Foods · 2024-01-31

You did not make and keep written procedures to fulfill the requirements that apply to the review and investigation of a product complaint.

Natural Ginger, Corp · Medley, Florida · Foods · 2023-12-22

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Quality risk managementPharmaceutical quality systemFood industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →